The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...

View Global Partners LP Common Units (GLP) current and estimated P/E ratio data provided by Seeking Alpha.

**NM signifies a non meaningful value. A dash signifies the data is not available.

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

In this blog post, we’ll delve into the details of GLP-1 Daily, explore the science behind GLP-1 medications, and assess whether Lemme’s new offering is a worthy addition to the wellness ...

Understanding how GLP-2 controls appetite could unlock new strategies for combating obesity, offering hope for more effective treatments. Study: The Possible Involvement of Glucagon-like Peptide-2 ...

Kourtney Kardashian just launched an herbal supplement called GLP-1 Daily. GLP-1 drugs like Ozempic and Wegovy are FDA-approved for diabetes and weight-loss. Wellness brands are scrambling to ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review ...

Jeffrey Flier is the former dean of Harvard Medical School. One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class of drugs.

WALTHAM, Mass., August 19, 2024--Global Partners LP (NYSE: GLP) (the "Partnership") today announced that its 2023 Schedule K-3 reflecting items of international tax relevance is available online.